Form 8-K - Current report:
SEC Accession No. 0001437749-25-008981
Filing Date
2025-03-24
Accepted
2025-03-24 16:38:12
Documents
17
Period of Report
2025-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250323_8k.htm   iXBRL 8-K 40326
2 EXHIBIT 4.1 ex_793525.htm EX-4.1 211494
3 EXHIBIT 99.2 ex_793526.htm EX-99.2 10064
8 img01.jpg GRAPHIC 8212
  Complete submission text file 0001437749-25-008981.txt   473376

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wint-20250318.xsd EX-101.SCH 3579
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250318_def.xml EX-101.DEF 11807
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250318_lab.xml EX-101.LAB 15858
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250318_pre.xml EX-101.PRE 12022
19 EXTRACTED XBRL INSTANCE DOCUMENT wint20250323_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25764638
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)